PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Health

FDA Announces Recall on Blood Pressure Medication—More Than 13,000 Bottles Affected Nationwide

A nationwide blood pressure medication recall is drawing widespread reporting following failed FDA dissolution testing.

11sources
12articles
10velocity
+181%since first seen
45d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

The FDA recalled more than 13,000 bottles of blood pressure medication nationwide after the drug failed dissolution testing. The agency later updated the recall, classifying it as a Class II risk level.

Epilogue added 39d ago, after coverage quieted.

The brief

Recent reporting across multiple news organizations details a nationwide recall involving a blood pressure medication after products failed standard testing parameters set by regulatory authorities. According to coverage from outlets including AOL.com, Good Housekeeping, Yahoo, WHIO TV, EatingWell, and Health.com, the action was initiated following failed dissolution testing. Subsequent updates from the Houston Chronicle, WUSA9, 10TV, and SuaraGarut.ID further specify that the regulatory classification for the recalled medication falls under a Class II risk level. The scope of the affected pharmaceuticals is highlighted extensively throughout the available reporting. Outlets such as AOL.com, Yahoo, EatingWell, and Health.com state that the recall impacts more than 13,000 bottles nationwide.

Meanwhile, reporting from the Grants Pass Tribune specifies a slightly higher count, indicating that the nationwide drug recall affects more than 13,500 bottles. WHIO TV uses the abbreviated reference of 13K bottles affected in its alert headlines, maintaining consistency with the broad digital coverage tracking the safety notice. Contextual background regarding the precise chemical formulation, manufacturer identity, and distribution channels remains limited within the provided headline data. While the Houston Chronicle and WUSA9 establish the connection to federal regulatory oversight and the specific Class II designation following dissolution test failures, the exact parameters of the risk categorization are not fully detailed in the current headlines. Coverage does not yet specify whether adverse health events have been formally linked to the recalled lots.

Ongoing updates from sources tracking health alerts will determine the next phases of the recall process. Readers following the story are directed by the initial reports to monitor regulatory databases for specific lot numbers, product names, and return instructions. The current data stream indicates that further announcements concerning distribution patterns and manufacturer responses will dictate how the affected bottles are handled nationwide.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 39d ago.

Quick answers

Why was the blood pressure medication recalled?

Coverage states the medication was recalled after failing FDA dissolution testing.

How many bottles are affected by the recall?

Reports state that more than 13,000 to 13,500 bottles are affected nationwide.

What risk level has been assigned to the recall?

The recall has been updated with a Class II risk level by regulatory authorities.

Coverage (12)

Topics

Related trends

\n \n \n \n \n \n \n